High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy

William S. Mow, Maria T. Abreu-Martin, Konstantinos A. Papadakis, Howard E. Pitchon, Stephan R. Targan, Eric A. Vasiliauskas

Research output: Contribution to journalArticlepeer-review

158 Scopus citations

Fingerprint

Dive into the research topics of 'High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences